ABOUT CYTIVA
With a rich heritage dating back hundreds of years, Cytiva brings a wealth of technical expertise and talent, a broad and deep portfolio, and exceptional service help researchers and biopharma advance therapeutics at every stage from discovery to delivery.
We supply the tools and support our customers need to work better, faster, and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes well-recognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™. Visit cytiva.com to learn more.
PRODUCT VIDEOS
FEATURED PRODUCTS
-
Gene therapies hold immense potential to provide long-lasting treatments for a wide range of diseases. At Cytiva, we offer GMP-compliant, end-to-end manufacturing solutions designed to support the development and commercialization of advanced medicines across multiple modalities – including AAV, adenovirus (AV), lentivirus (LV), plasmid DNA (pDNA) and exosomes. Our dependable suite of technologies and expertise ensures scalability, quality, and regulatory confidence at every stage of your journey.
-
Discover a medium that supports high-density HEK293 growth and robust AAV titers across scales for bioprocessing teams seeking consistency and scalability in viral vector manufacturing.
-
Platform of automated, single-use systems for tangential flow filtration at multiple scales.
-
Accelerate your gene therapy manufacturing with the Xcellerex™ X-platform – a next-generation single-use bioreactor system designed for viral vector workflows.
-
Optimize your cell line strategy for better viral vector production.
-
Whether you're looking to boost performance, enhance your capabilities, or simply get consistent, high-quality results, HyClone™ peak expression medium and HyClone™ prime expression medium are the solutions for you.
-
ÄKTA ready™ 450 system is a single-use liquid chromatography system.
-
The LevMixer™ 10 L single-use mixing system is a low volume mixer designed for both upstream and downstream applications.
-
The iCELLis™ bioreactor system is an automated, single-use, fixed-bed bioreactor that provides excellent cell growth conditions for adherent cells.
-
Gene therapy holds promise for treating genetic diseases, but the path from concept to product is complex. Learn how to navigate each step of the viral vector workflow with greater speed and confidence.
-
Examine a scalable, benchtop mixing system designed for sensitive fluids and GxP environments that supports automated control, traceability, and compliance from early development through production.
-
Explore media solutions for viral vector production that support HEK293 and insect cells, with custom development, analytical testing, and scalable preparation tools to optimize performance.
-
Support high transfection efficiency and viral titers in HEK293 cells with a chemically defined, hydrolysate-free formulation that enables seamless scale-up and shows improved viability over alternatives.
-
Support high-yield viral vector production with media designed for transfection efficiency, scalability, and reduced aggregation in HEK293 cells, ideal for AAV and LV workflows.
-
Discover a system with a flexible synthesis scale, intuitive software, and robust process control that is ideal for labs moving from research to production.
-
Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.
-
Off-the-shelf, research use only lipid nanoparticle (LNP) reagents to deliver RNA into T-cells.
-
Discover a single-use bioreactor system for cell culture that features advanced sensors, user-friendly software, and flexible operation modes, ensuring reliable performance in regulated environments.
-
Discover how you can enhance your gene therapy efforts with a comprehensive range of cell lines designed for adeno-associated virus (AAV) production.
-
Discover an off-the-shelf transient cell line engineered for speed and simplicity, enabling seamless integration into existing researchers' and technicians' workflows.
WEBINARS AND PODCASTS
APPLICATION NOTES
- Cell Culture Media Mixing In A Benchtop Single-Use Mixer
- Assessing Particle Generation In A Single-Use Mixing System
- HyClone™ Prime Expression Medium
- A Scalable, Benchtop Mixing System For Sensitive Fluids
- HyClone™ Peak Expression Medium
- A Revolutionary Single-Use Rocking Bioreactor System
- A Transient Cell Line To Produce rAAV With Low-Level hcDNA Encapsidation
- An Off-The-Shelf Transient Cell Line For Viral Vector Production
- How To Successfully Isolate Your T Cells
- Automated Cell Washing And Formulation In CAR T Cell Therapy Manufacturing
CONTACT INFORMATION
Cytiva
100 Results Way
Marlborough, MA 08855-1327
UNITED STATES
Phone: 800-526-3593
FEATURED ARTICLES
-
AAV vectors hold promise for gene therapy, but removing product-related impurities remains a challenge. Learn how cell line development and process optimization are advancing rAAV production.
-
Cell culture media isn’t one-size-fits-all. Learn how media composition, customization, and analytics can dramatically improve cell growth, productivity, and product quality for complex processes.
-
Scalable rAAV production is achievable with a transient cell line and optimized bioreactor setup, delivering high titers and reduced impurities, now validated at 200 L scale for commercial readiness.
-
Fixed-bed bioreactors simplify the scale-up of viral vector production. Discover a system that bridges development and manufacturing with data confirming consistent performance across scales.
-
Explore how powder media and sterile fluid handling can reduce contamination risk and improve efficiency in viral vector production, especially for HEK293-based AAV workflows.
-
Explore a high-yield, scalable process for hMSC-derived exosome production using fixed-bed bioreactors, with strong performance in purity, recovery, and biological activity.
-
Get a clear view of oligonucleotide development from synthesis to purification and filtration with practical insights to help you streamline workflows and stay ahead in the fight against disease.
-
Discover a practical guide to selecting filters for bioprocessing applications that are matched to product type, process stage, and performance needs such as virus filtration, clarification, and TFF.
-
Explore how to simplify your downstream viral vector manufacturing with integrated, end-to-end strategies that reduce delays and accelerate your path to the clinic.
-
Explore how lipid nanoparticles are revolutionizing cell therapy workflows to enable the precise delivery of mRNA and gene editing tools for next-generation treatments like CAR T and HSC therapies.
NEWS
- Cytiva And Asimov Collaborate On Next Generation Cell Line Design And Process Development
- Innovation And Automation Are Driving Forces Behind Next Generation Cell Therapy Manufacturing Platform From Cytiva
- Precision NanoSystems And Aurora Vaccines Join Forces To Accelerate The Development Of Vaccine Candidate For Hepatitis C Virus
- Precision NanoSystems And Replicate Bioscience In Licensing Deal To Scale Up Genomic Medicines
- Cytiva And Multiply Labs Collaborate To Automate Cell Therapy Manufacturing
- Cytiva And Brooks Life Sciences To Enhance Automation In Cold Chain Solutions
- G-CON Manufacturing And GE Healthcare Announce Collaboration To Advance Early-Stage Cell Therapy And Viral Vector Manufacturing
- Scaling Up Cell Therapy Manufacturing In Guangzhou
- GE Healthcare Life Sciences Opens Cell And Gene Therapy Asia Technology Center In Shanghai